Emily Marden

1.1k total citations · 1 hit paper
15 papers, 698 citations indexed

About

Emily Marden is a scholar working on Plant Science, Management of Technology and Innovation and Molecular Biology. According to data from OpenAlex, Emily Marden has authored 15 papers receiving a total of 698 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Plant Science, 5 papers in Management of Technology and Innovation and 4 papers in Molecular Biology. Recurrent topics in Emily Marden's work include Genetically Modified Organisms Research (7 papers), Intellectual Property and Patents (5 papers) and Biomedical Ethics and Regulation (2 papers). Emily Marden is often cited by papers focused on Genetically Modified Organisms Research (7 papers), Intellectual Property and Patents (5 papers) and Biomedical Ethics and Regulation (2 papers). Emily Marden collaborates with scholars based in Canada, United States and Italy. Emily Marden's co-authors include Ciro Abbondanza, Myles Brown, Shlomit Halachmi, Susan R. McCouch, Michael Halewood, W. Powell, Paul Kersey, Tinashe Chiurugwi, Eric W. Welch and J Mozafari and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and New Phytologist.

In The Last Decade

Emily Marden

15 papers receiving 674 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Estrogen Receptor-Associated Proteins: Possible Mediators of Hormone-Induced Transcription

1994 531 citations Shlomit Halachmi, Emily Marden et al. Science profile →

Peers

Countries citing papers authored by Emily Marden

Since Specialization

Citations

This map shows the geographic impact of Emily Marden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Marden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Marden more than expected).

Fields of papers citing papers by Emily Marden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Marden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Marden. The network helps show where Emily Marden may publish in the future.

Co-authorship network of co-authors of Emily Marden

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Marden. A scholar is included among the top collaborators of Emily Marden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Marden. Emily Marden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	International agreements and the plant genetics research community: A guide to practice 2023 ·Proceedings of the National Academy of Sciences ·Emily Marden, N. Ruaraidh Sackville Hamilton, Michael Halewood, Susan R. McCouch	10
2	Plant genetic resources for food and agriculture: opportunities and challenges emerging from the science and information technology revolution 2018 ·New Phytologist ·Michael Halewood, Tinashe Chiurugwi, Ruaraidh Sackville Hamilton, (unknown), Emily Marden, Eric W. Welch, Frank Michiels, J Mozafari, (unknown), Nicola J. Patron, Paul Kersey, Ruth Bastow, Shawn Dorius, (unknown), Susan R. McCouch, W. Powell	73
3	Reflections on FDA Draft Guidance for Products Containing Nanomaterials: Is the Abbreviated New Drug Application (ANDA) a Suitable Pathway for Nanomedicines? 2018 ·The AAPS Journal ·Emily Marden, Ioanna Ntai, (unknown), Beat Flühmann	17
4	International agreements may impact genomic technologies 2017 ·Nature Plants ·Emily Marden	7
5	U.S. ratification of Plant Treaty: benefit sharing ambiguity for plant genomics researchers does not change 2017 ·Genetic Resources and Crop Evolution ·Emily Marden	3
6	Open Source Drug Development: A Path to More Accessible Drugs and Diagnostics? 2010 ·University of Minnesota Digital Conservancy (University of Minnesota) ·Emily Marden	3
7	Genomics and Intellectual Property: Considering Alternatives to Traditional Patenting 2008 ·DigitalGeorgetown (Georgetown University Library) ·Emily Marden, (unknown), David Hartell, (unknown), Ben Warren	5
8	The Policy Context and Public Consultation: A Consideration of Transgenic Salmon 2006 ·Emily Marden, Holly Longstaff, (unknown)	4
9	The New Dietary Ingredient Safety Provision of DSHEA: A Return to Congressional Intent 2005 ·American Journal of Law & Medicine ·Scott A. Bass, Emily Marden	1
10	The StarLink controversy: the competing frames of risk disputes 2004 ·International Journal of Biotechnology ·Dorothy Nelkin, Emily Marden	3
11	Risk and Regulation: U.S. Regulatory Policy on Genetically Modified Food and Agriculture 2003 ·Boston College law review ·Emily Marden	19
12	Displaced agendas: current regulatory strategies for germline gene therapy. 2000 ·PubMed ·Emily Marden, Dorothy Nelkin	1
13	The Neem Tree Patent: International Conflict Over the Commodification of Life 1999 ·Boston College international and comparative law review ·Emily Marden	20
14	Cloning: a business without regulation. 1999 ·PubMed ·Emily Marden, Dorothy Nelkin	1
15	Estrogen Receptor-Associated Proteins: Possible Mediators of Hormone-Induced Transcription breakdown → 1994 ·Science ·Shlomit Halachmi, Emily Marden, (unknown), (unknown), Ciro Abbondanza, Myles Brown	531

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact